Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
about
A host YB-1 ribonucleoprotein complex is hijacked by hepatitis C virus for the control of NS3-dependent particle productionY-box-binding protein 1 interacts with hepatitis C virus NS3/4A and influences the equilibrium between viral RNA replication and infectious particle productionImmunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzeesModeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived SystemsNew hepatitis C virus drug discovery strategies and model systemsHuman Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex FormationStudying Hepatitis C Virus: Making the Best of a Bad VirusHepatitis C Virus Genotype 1a Growth and Induction of AutophagyScavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic CellsEfficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like ParticlesMouse models for the study of HCV infection and virus–host interactionsHepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutationHepatitis C virus replicons: dinosaurs still in business?A genome-wide genetic screen for host factors required for hepatitis C virus propagationTim-3 negatively regulates IL-12 expression by monocytes in HCV infection.Involvement of MAP3K8 and miR-17-5p in poor virologic response to interferon-based combination therapy for chronic hepatitis C.Single strain isolation method for cell culture-adapted hepatitis C virus by end-point dilution and infection.Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycleDifferential transcriptional responses to interferon-alpha and interferon-gamma in primary human hepatocytes.Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.Active RNA replication of hepatitis C virus downregulates CD81 expression.Genome-wide RNAi screen reveals a new role of a WNT/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses.Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine modelDynamic Interaction of Stress Granules, DDX3X, and IKK-α Mediates Multiple Functions in Hepatitis C Virus InfectionRibavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture modelsRecent contributions of in vitro models to our understanding of hepatitis C virus life cycle.Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells.Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future PerspectivesRole of stress-induced NKG2D ligands in liver diseases.Experimental models of hepatitis B and C - new insights and progressSerum-derived hepatitis C virus 1a infection of human astrocyte cell line SVG.Viral Load Analysis of Hepatitis C Virus in Huh7.5 Cell Culture System.Development of hepatitis C virus genotype 3a cell culture system.The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies.Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP).Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients.
P2860
Q24320237-BD0DF438-731F-4CA9-BC56-31F103F8C124Q24323080-991AB1DA-8598-4CC3-9118-E4AC3594E314Q24685256-3BFDDE85-B477-4750-BF03-C29F355854F0Q26799933-F96ED782-7B46-49E6-A8FB-75914DCEF4BFQ26851159-23B64391-A32D-4F91-942C-E27739F1ACB3Q27468561-A08092D0-7A10-46B0-958D-9CDD09A5CFDAQ27481034-C89ED443-45B2-4634-BA3E-0D756B8F9D8EQ27485449-0F063589-2DD6-47A8-B580-95B17686E55AQ27485559-E7C562F6-0620-448A-9C1E-E0699730C3D4Q27486405-A6776BEA-A4AA-45CF-B397-248187B7953CQ27486807-F91029FE-377F-4230-A5CD-784F626FA6D3Q27486836-C389249E-8219-4723-9F1C-87466720B645Q27488905-DB0CE98C-C1DD-47E1-804D-E82F31E95CAFQ27489773-383C3D85-182B-4A2F-86CE-2CD704687451Q30432023-A02FD8F9-09B2-434C-92F0-75614807BC17Q33599325-BBCD8D8D-0967-4919-92A9-61D9F1A815C0Q33646044-99948965-EA38-4FE7-A992-474F9A806000Q33877391-3CAD9B6D-F447-42FB-9B8A-4A9064E3F0ECQ33893794-778854F7-05D8-4D5E-A5FA-B6B5F027EA4CQ34163327-82F0375B-4B09-482D-9157-F8C5B01A31E4Q34489239-22586169-7C97-4B1A-962D-C6982BFF6E56Q34563532-C5DF7B21-FEB2-4DEC-B0D3-C94E694B79D2Q34778497-3033FD07-EDC6-4067-AFFE-0689335335D6Q34992715-AEAE43B3-5E15-46CF-8DBB-317D9605EB55Q35115534-E8E5DF69-6001-4A4C-8D68-F4FAFDCF3962Q35140067-6D625565-3E15-4361-BF44-9EB448DDEDDFQ35641517-BD4573D9-12CE-4055-9EFC-C5D776632BBFQ36399860-37E0D990-38A7-4D72-AAB8-2DDBFAE35793Q36933791-6F6DFDA9-63A0-4F9C-8F0A-9CED7B97A62AQ37418256-3056A5CD-B6E1-4638-8283-DD68734C0C9DQ37945171-C6918B73-AE27-4499-83E0-CA477ED6A7B8Q37957971-D21CFB4A-EC6A-4923-9C69-3F2606840A5DQ38778496-04AB4B15-F387-4DD0-86E9-1EDE1A8086BEQ38827708-F80E4EE8-2687-4F82-B180-E2792CA49340Q38842372-7B2C352E-7F22-4D0C-B931-C4C5F4F36713Q38998425-002BEF17-2E35-49AA-82FC-7FBF510D3E80Q39084971-D6BAB5E3-2AB8-47EE-8551-F4BCB44925C9Q39598862-C709FEC3-226A-43F6-91CF-5AC89871F9DFQ39631188-9CFFAAEA-B561-4BD2-A546-6EFC2CC52E6FQ40142985-CCEB92B6-426E-4647-97C2-A19A69C230E6
P2860
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
@ast
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
@en
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
@nl
type
label
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
@ast
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
@en
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
@nl
prefLabel
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
@ast
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
@en
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
@nl
P2093
P2860
P3181
P356
P1433
P1476
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
@en
P2093
Krishna Murthy
Ronda K Sapp
Satoru Saito
T Jake Liang
Takanobu Kato
Takuya Matsumura
Theo Heller
P2860
P304
P3181
P356
10.1128/JVI.02334-06
P577
2007-05-01T00:00:00Z